Area of research
Hematology · Genetics
Research interest
Research interests include Acute Myeloid Leukemia Research, Myeloproliferative Neoplasms: Diagnosis and Treatment, Chronic Myeloid Leukemia Treatments, and Eosinophilic Disorders and Syndromes.
Erdheim-Chester disease associated with myeloid neoplasm: Clinical features, molecular landscape, and treatment outcomes.
A novel PML germline variant as a candidate predisposing genetic aberration in familial acute myeloid leukaemia.
Metabolic adaptation pilots the differentiation of human hematopoietic cells.
Clinical and biological impact of ATP-binding cassette transporter activity in adult acute myeloid leukemia.
Prognostic impact of DDX41 germline mutations in intensively treated acute myeloid leukemia patients: an ALFA-FILO study.
Macrophage migration inhibitory factor is overproduced through EGR1 in TET2low resting monocytes
Macrophage migration inhibitory factor is overproduced through EGR1 in TET2<sup>low</sup> resting monocytes.
Germline ATG2B/GSKIP-containing 14q32 duplication predisposes to early clonal hematopoiesis leading to myeloid neoplasms.
Circulating cytokines present in multiple myeloma patients inhibit the osteoblastic differentiation of adipose stem cells.
Aberrant DNA methylation impacts HOX genes expression in bone marrow mesenchymal stromal cells of myelodysplastic syndromes and de novo acute myeloid leukemia.
Isocitrate dehydrogenase inhibitors as a bridge to allogeneic stem cell transplant in relapsed or refractory acute myeloid leukaemia.
Prognostic impact of early minimal residual disease combined with complete molecular evaluation in acute myeloid leukemia with mutated <i>NPM1</i>: a single center study.
Publisher Correction: Somatic genetic rescue of a germline ribosome assembly defect.
Somatic genetic rescue of a germline ribosome assembly defect
Somatic genetic rescue of a germline ribosome assembly defect.
VEXAS syndrome: still expanding the clinical phenotype.
Dominance of an <i>UBA1</i> mutant clone over a <i>CALR</i> mutant clone: from essential thrombocytemia to VEXAS.
Unexplained recurrent implantation failures: Predictive factors of pregnancy and therapeutic management from a French multicentre study.
Clonal dominance is an adverse prognostic factor in acute myeloid leukemia treated with intensive chemotherapy.
Unexplained recurrent miscarriages: predictive value of immune biomarkers and immunomodulatory therapies for live birth.
Shwachman-Diamond syndrome and solid tumors: Three new patients from the French Registry for Severe Chronic Neutropenia and literature review.
A circulating subset of BRAF<sup>V600E</sup> -positive cells in infants with high-risk Langerhans cell histiocytosis treated with BRAF inhibitors.
Atypical CD5 and CD10 coexpression in a splenic marginal zone lymphoma.
High prevalence of clonal hematopoiesis in the blood and bone marrow of healthy volunteers
High prevalence of clonal hematopoiesis in the blood and bone marrow of healthy volunteers
Clonal haematopoiesis is increased in early onset in systemic sclerosis.
Targeted molecular characterization shows differences between primary and secondary myelofibrosis.
Fractionated gemtuzumab ozogamicin in association with high dose chemotherapy: a bridge to allogeneic stem cell transplantation in refractory and relapsed acute myeloid leukemia.
Annexin-A5 resistance and non-criteria antibodies for the diagnosis of seronegative antiphospholipid syndrome.